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Summary: Hen egg yolks have been recognized as convenient source for specific antibodies, although their utility
in diagnostic applications has been hampered by the lack of efficient purification methods. In the present study,
anti-human parathyrin antibodies were raised in rabbits, hens and mice using synthetic human parathyrin peptide
(1—84) as an antigen. The antibodies were affinity purified with amino- (1-30) and carboxy- (49-89) terminal
peptides of parathyrin under highly alkaline elution conditions, and were evaluated for their diagnostic value in
different combinations in immunoenzymometric assay (IEMA) format. A pair of hen egg yolk antibodies were
subjected to further methodological validation in the IEMA that was constructed with the N-terminal capture and
C-terminal detection antibodies. The synthetic intact human parathyrin (1—84) peptide served as a standard. This
within-day IEMA procedure turned out to be sensitive and it correlated well with the two independent intact
parathyrin immunoradiometric assays. As shown in the present study, the immuno affinity purification with the
highly alkaline elution conditions provides an efficient method for utilization of hen egg yolk antibodies. This is
the first report on an application making use of a combination of two hen egg yolk antibody preparations in
measuring a homogeneous protein in human serum.
Introduction
Hen egg yolk antibodies have aroused interest because
of their fast, convenient and inexpensive manufacture
when compared with mammalian antibodies. Because of
these advantages together with some structural and func-
tional properties, these antibodies have been examined
as potential therapeutic proteins against some gastroin-
testinal pathogens. For diagnostic applications, avians as
more distant phylogenetic species from mammals, may
provide new epitopes especially for antigens of mamma-
lian origin. Utility of the yolk antibodies has been ham-
pered by the lack of efficient purification methods since
many, especially diagnostic applications, require ex-
tremely pure antibody preparations. Crude extraction
methods published so far produce almost homogeneous
antibody preparations (1, 2) but to meet the quality
requirements for being linked to solid supports only the
purification methods based on antigen affinity are pre-
ferred. The acidic elution buffers detaching antibodies
from their antigens tend to cause irreversible denatur-
ation of especially egg yolk antibodies leading to re-
duced immunoreactivity and poor applicability of such
antibodies. In this study we optimized the elution condi-
tions based on highly alkaline buffer, 0.05 mol/1 diethyl-
amine at pH 11.5, for egg yolk antibodies raised against
the synthetic peptides of human parathyrin. These anti-
bodies together with the rabbit and mice antibodies also
raised against the intact parathyrin peptide (1—84) were
investigated for their antigen binding properties with the
direct and immunoenzymometric (IEMA) techniques.
The IEMA making use of hen egg yolk antibodies which
recognize epitopes at the opposite ends of the intact
parathyrin polypeptide was subjected to methodological
and analytical evaluation with samples from normal and
hyperparathyroid subjects. As indicated in the present
study, the affinity purification of the egg yolk antibodies
under highly alkaline conditions produce reactive anti-
bodies that could be utilized in the sensitive IEMA de-
tecting intact human parathyrin with the performance
well comparable with the presently available commercial
assays. This IEMA provides sensitive non-radiometric
within-day procedure for measuring human parathyrin
in serum of plasma.
Materials and Methods
Materials and chemicals
The cell culture reagents and plastic ware were from Nunc
(Roskilde, Denmark), the commercial antibodies and IEMA rea-
gents were from Zymed (San Francisco, CA, USA), and the other
chemicals were from Sigma (St Louis, MO, USA) unless otherwise
stated. Synthetic peptides of human parathyrin (1-30), (49-84)
and (1-84) were synthesised by EriLab Ltd, Kuopio, Finland. The
peptides were app. 98% pure as confirmed by Edman degradation
and mass spectrometric analysis. One milligram of the parathyrin
(1 —84,1 -30 and 49-84) peptides were linked to key hole limpets
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haemocyanin (KLH, Calbiochem, CA, USA) using the glutaralde-
hyde method (4) and stored in small aliquots at —24 °C until used
for immunizations. The peptides were chosen on the basis of their
physiological properties, which were determined from the amino
acid sequence illustrating structural orientation and antigenicity (5,
6). The (1-30) and (49-84) peptide conjugates were used for tit-
reing of the terminal specific antibodies. All the experimental ani-
mals were provided by the National Centre of Experimental Ani-
mals (University of Kuopio, Finland), and were treated according
to the ethical standards set for experimental animals in Finland.
Immunization
For the monoclonal antibodies, Balb/c mice were immunized (i. p.)
with 400 μg of the key hole limpet haemocyanin-parathyrin
(1 —84) conjugate in Freund's complete adjuvant, followed by four
boosters given at four to five week intervals with the same amount
of antigen in Freund's incomplete adjuvant. The hybridomas were
prepared with the standard procedures using mouse P3X63-Ag8.53
myeloma cells (ATCC-CLR 1583, USA) as a fusion partner. For
the polyclonal antibodies, rabbits (New Zealand White) and hens
(Leghorn) were immunized (i. m.) with the key hole limpet haemo-
cyanin-parathyrin (1 — 84) conjugate, followed by four boosters
given at three (rabbits) and two (hens) week intervals as above.
Purification of antibodies
Based on the titre analysis, the eggs laid between days 30—62
were chosen for the crude extraction of the egg yolk antibodies as
described by Akita & Nakai (1) and Kokko et al. (2). For the affinity
purification of the rabbit immunosera, hybridoma media and the
crude egg yolk extracts, 5 mg of the parathyrin amino- and car-
boxy-terminal peptides were linked to l g of cyanogen bromide
activated Sepharose CL 4 B (Pharmacia, Uppsala, Sweden) using
the manufacturer's instructions. Crude egg yolk extract (100—200
mg) in 20 ml of phosphate-buffered saline (0.05 mol/1 Na2HPO4,
0.15 mol/1 NaCl, pH 7.4), 5 ml of the rabbit immunoserum diluted
1 : 5 with phosphate-buffered saline containing 20 mmol/1 of
EDTA, or 1000 ml of the hybridoma media were passed through
the column and the column was washed with phosphate-buffered
saline until no detectable amount of protein emerged. Fractions of
1 ml were collected using 0.05 mol/1 diethylamine, pH 11.5, into
tubes containing 100 μΐ of 1 mol/1 Tris-HCl, pH 7.4. The protein
concentration of the purified antibody preparations was estimated
according to absorption coefficients at 280 nm; 13 for 1% solution
of mouse IgG, and 14 for 1% solution of hen egg yolk antibodies
and rabbit IgG.
Biotinylated antibodies
The affinity purified antibodies were dialyzed against 0.1 mol/1
sodium bicarbonate, pH 8.3, and biotinylated at a concentration of
1 g/1 using 10 μg of biotin succinimide ester (Zymed, USA) per
1 mg of protein, as described by Harlow & Lane (7). After dialyza-
tion with phosphate-buffered saline, 50 g/1 of bovine serum albu-
min, 20 mmol/1 of EDTA and 0.5 g/1 of sodium azide as their final
concentration were added for storage at 4 °C. For these experi-
ments, the egg yolk and the mouse IgM-class monoclonal antibod-
ies reacting against the (49—84) peptide were biotinylated.
Standard
Ten milligrams of the synthetic intact parathyrin peptide were solu-
bilized with 10 ml of 0.1 mol/1 sodium carbonate, pH 9.6. For stor-
age at -24 °C, 0.5 g/1 of sodium azide and 20 mmol/1 of EDTA
were added. The actual standard concentrations were prepared from
the stock solutions by making stepwise dilutions. Repeated freeze-
thawing of the standards was avoided.
Serum samples
Peripheral blood was drawn into ice-cold vacuum tubes and these
were placed on ice immediately after sampling. After clotting, the
serum was separated by centrifugation at 2000 g for 15 min at 4 °C
and stored in small aliquots at -20 °C until analyzed. Parathyrin
from the human serum was depleted by intensive dialysis against
phosphate-buffered saline. All human material was treated accord-
ing to ethical standards of Kuopio University Hospital, Finland.
Parathyrin IEMA
Polystyrene microtitration plates were coated overnight with 200
μΐ per well of capture antibodies in 0.1 mol/1 Tris-HCl-0.15 mol/1
NaCl, pH 8.8, at a concentration of 10 mg/1. The wells were washed
once with a washing buffer (10 mmol/1 Tris-HCl, 0.15 mol/1 NaCl,
0.5 ml/1 Tween 20, pH 7.4) and blocked with 10 g/1 bovine serum
albumin in phosphate-buffered saline for 2 hours. The standards
diluted with the assay buffer (20 g/1 bovine serum albumin in phos-
phate-buffered saline, 20 mmol/1 EDTA, 0.5 g/1 proclin, 0.5 ml/1
Tween 20, pH 7.4), and 200 μΐ aliquots of the serum or plasma
samples were added to the wells and incubated in a plate shaker at
room temperature for four hours followed by washing five times
with the washing buffer. Two hundred microlitres of the tracers
were added to the wells and incubated for another hour at room
temperature. After washing with the washing buffer, 200 μΐ of
streptavidin or species specific secondary antibodies conjugated to
horse radish peroxidase were added and they were incubated for
l h at room temperature. The wells were washed as above and
developed with the peroxidase substrate (ABTS) and read at 405
nm. The blanks included incubations with the assay buffer and the
parathyrin-depleted human serum samples. The antibodies recog-
nizing the (1 -30) peptide were used for coating. The coated plates
remained stable for at least 3 months when stored carefully sealed
under humid conditions at 4—8 °C. In the present experiments, the
coated plates were used within 2 weeks.
Other assays
For comparative analysis of intact parathyrin, commercial IRMA
methods from INCSTAR (N-test PTH, Incstar Laboratories, Still-
water, MN, USA) and Immunodiagnostic System (Gamma BCT
Intact PTH, Boldon, UK) were used as recommended by the manu-
facturers.
Results
Earlier reports have indicated that the major antigenic
site in human parathyrin lies in the carboxy-terminal end
of the polypeptide, and only a poor or undetectable re-
sponse is directed towards the amino- and mid-molecule
sites. This was also found in the present investigation,
since the mean titres of the amino- and carboxy-terminal
specific antibodies in the mice (n = 5) and rabbits
(n = 3) sera were 1 : 100 and 1 : 28000 at their peak,
respectively. Also, only the carboxy-terminal peptide-
specific monoclonal antibodies of IgG and IgM classes
were obtained. In contrast, positive reactions at very
high dilutions were measured from the crude hen yolk
extracts against both of the terminal peptides, peaking
shortly after the second antigen exposure (four weeks
after the first one). Optimally, up to 0.98 mg and 1.12
mg of the specific antibodies were obtained from an egg
yolk against the amino- and carboxy-terminal ends,
respectively.
Immunoaffinity chromatography
For many applications, only affinity-pure quality of anti-
bodies is acceptable. Hen egg yolk antibodies especially
are vulnerable to irreversible denaturation and loss of
their biological activity in acidic conditions (3). As
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shown in figure 1, acidic elution buffers at the pH scale
from 3.5 to 4.0 were able to detach the antigen-antibody
complex but caused irreversible denaturation and loss of
the biological activity of the hen egg yolk antibodies.
Instead, the alkaline elution buffer, 0.05 mol/1 diethyl-
amine at pH 11.5, eluted the bound antibodies sharply
and preserved their binding activity.
Development of the parathyrin IEMA
Although several antibody combinations tested in an
IEMA format reacted specifically against the intact
parathyrin, the construct of affinity purified hen anti-
parathyrin (1—30) for the capture and the biotinylated
hen anti-parathyrin (49—84) for the detection gave the
best assay sensitivity and resolution (fig. 2). This con-
struct was further evaluated for assay performance.
The typical standard profile of this IEMA is shown in
figure 3. The curve represents the mean values (n = 3)
of three assays done on consecutive days. As calculated
from the data, the theoretical limit of detection is 1.23
ng/1 (3 SDblank + blank, n = 10). The analytical limit
of detection defined with a normal human serum after
stepwise dilution was 2.4 ng/1 (fig. 4).
Intra-assay variation determined with five human serum
samples varied from 2.3 to 9.2 CV% (mean 7.1%, tab.
1) at the parathyrin concentration of 7.5—211 ng/1. Inter-
assay variation determined with the same samples varied
from 6.6 to 10.2 CV% (mean 9.1%; tab. 1). The assay
imprecision at a very low level (2.5 ng/1) was 17.2 and
19.2 CV% (tab. 1).
Analytical recovery after the addition of a known
amount of the synthetic parathyrin (1—84) standard pep-
3.0-t
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Fig. 1 Elution diagrams and reactivity of the anti-parathyrin49_84
egg yolk antibody using 0.05 mol/1 of diethylamine, pH 11.5 (·),
(2) 0.05 mol/1 of glycine, pH 4.0 (φ), (3) 0.05 mol/1 of glycine,
pH 3.5 (o), and (4) 0.05 mol/1 of glycine, pH 3.8 (Δ), as elution
buffers. The affinity purification was done as described in the
Methods. The reactivity of the purified antibodies was measured
by direct ELISA against the parathyrin (1—84) polypeptide using
stepwise dilutions from the pooled antibody preparations contain-
ing equal concentration of antibodies. The arrow indicates the point
of-starting the eluation with the buffers mentioned above.
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Fig. 2 Utility of the purified antibodies to detect the parathyrin
(1 — 84) polypeptide in IEMA format was tested in different combi-
nations. The IEMA was done as described in the text using the
following combinations: the egg yolk antibody against the (1—30)
peptide for capture and the biotinylated egg yolk antibody against
the (49-84) peptide for detection (·), the egg yolk antibody
against the (1—30) peptide for capture and the rabbit antibody
against the 49-84 peptide for detection (φ), the egg yolk antibody
against the (1 —30) peptide for capture and the mouse monoclonal
(IgG-class) antibody against the (49-84) peptide for detection (·),
the mouse monoclonal (IgG-class) antibody against the (49-84)
peptide for capture and the biotinylated mouse monoclonal (IgM-
class) antibody against the (1—30) peptide for detection (A). The
reactions were detected with species-specific antibodies (horse rad-
ish peroxidase-conjugates), or with streptavidin horse radish perox-
idase conjugate (biotinylated antibodies). Each point is the mean
value of three analyses.
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Fig. 3 A typical standard profile (n = 3) of the intact parathyrin
IEMA showing the linear measuring range on a semilogarithmic
scale.
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Fig. 4 The limit of detection analysed after serial dilution of hu-
man serum sample (n = 3), with the assay buffer containing 25%
(as final concentration) of the parathyrin-depleted human serum.
The dashed line represents the absorbance mean value of three
blank reactions (absorbance mean = 0.209, SD = 0.014).
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tide into human serum varied from 82% to 116% (mean
99.1%; n = 7), and after serial dilution with the para-
thyrin-depleted serum from 91% to 108% (mean
101.6%; n = 9, tab. 2).
Neither the standard peptide after trypsin digestion nor
the amino- or carboxy-terminal peptide of the human
parathyrin produced positive reaction in the IEMA (fig.
5). The (1—84) polypeptide used as a standard for the
Tab. 1 Imprecision of the parathyrin IEMA.
Sample number 1 2 3 4 5 6
Intra-assay imprecision
Mean of 7.5 15.6 30.4 100.6 210.8 2.43
9 replicates [ng/1]
Coefficient of 9.2 7.5 2.4 4.2 2.3 17.2
variation (%)
Inter-assay imprecision
Mean of 7.9 12.5 28.4 102.5 197.8 2.67
4 replicates [ng/1]
Coefficient of 6.6 10.5 5.2 7.1 6.3 19.2
variation (%)
Tab. 2 Analytical recovery of the parathyrin IEMA.
A. After serial dilution of human serum
a
1
1
1
1
1
1
1
Dilution
:2
:4
:8
: 16
:32
:64
Calculated
concentration
[ng/1]
374
187
93.5
46.8
23.4
11.6
5.53
Analyzed
concentration
[ng/1]
366
192
91.1
49.9
19.2
10.3
6.41
Recovery
[%]
97.8
104.8
97.4
106.6
82.1
88.8
115.9
Mean 99.1
a
 Parathyrin-depleted human serum in the assay buffer (1:4) was
used as a diluter.
B. After addition of standard to human serum
bBase
[ng/1]
4.6
4.6
4.6
4.6
4.6
4.6
4.6
4.6
4.6
Added
amount
[ng/1]
1.23
2.46
4.92
9.84
19.7
39.6
79.2
98.4
196.8
Analyzed
amount
[ng/1]
6.21
6.98
10.3
13.2
26.4
43.7
87.7
101.3
199.4
Recovery
[%]
106.5
98.8
108.2
91.4
108.6
98.9
104.7
98.3
99.0
Gamma BCT Intact PTH IRMA reacted with a slightly
lower affinity from our own standard, giving a standard
profile as shown in figure 5. Human serum stored at
room temperature for several days or dialyzed inten-
sively against phosphate-buffered saline failed to react
positively in the parathyrin IEMA, suggesting the speci-
ficity of the assay against intact or almost intact para-
thyrin.
Comparison of the present IEMA with the commercial
methods for intact parathyrin showed a strong correla-
tion, r = 0.980 (p < 0.001; n = 40; y = 15.58 + 0.69x)
with N-tact PTH IRMA, and r = 0.965 (p < 0.0001;
n = 68; y = -1.72 + 0.87x) with Gamma BCT Intact
PTH IRMA.
The tentative reference range, as analysed with 72 serum
samples donated by subjects (26 men of ages 12—60a
and 46 women of ages 7—49 a) having no known disor-
ders affecting the concentrations of parathyrin in sys-
temic circulation, was 9.6—64.7 ng/1 (at 95% confi-
dence level).
In a follow-up study, we measured the level of intact
parathyrin and total calcium in the serum of two patients
who suffered from secondary hyperparathyroidism, be-
fore and after partial parathyroidectomy. Shortly after
the operation, the earlier elevated level of intact para-
thyrin had fallen to normal concentration, or was even
undetectable by the comparison method, leading to nor-
malization of total calcium in the serum of these pa-
tients (fig. 6).
Discussion
Along with the development of more gentle and efficient
purification techniques for hen egg yolk immunoglobu-
lins, hens as a source for specific immunoglobulins have
arisen interest because of their extremely high producti-
vity and also because hens make it easier to satisfy
2.0 -ι
1.5-
1.0-
0.5-
0.0-
Mean 101.6
b
 Mean concentration of the human serum (SD 0.12, η = 3).
1 10 100 1000 10000
Parathyrin [ng/1]
Fig. 5 Reactivity of the different parathyrin peptides in the pre-
sent IEMA. In this figure, the 1 -84 peptide (·), the 49-84 peptide
(4), the 1-30 peptide (·), the trypsin digestion of the 1-84 pep-
tide (A), and the standards of the Gamma BCT Intact PTH IRMA,
Immunodiagnostic Systems (D) are shown.
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Fig. 6 Intact parathyrin and calcium (φ) concentrations before
and after parathyroidectomy (time = 0) in the serum from the two
patients with secondary hyperparathyroidism (A and B). The intact
parathyrin was measured with the Gamma BCT Intact PTH IRMA
(Immunodiagnostic Systems, U. K. (o)) and the present intact para-
thyrin IEMA (·). The lowest detectable concentrations for the as-
says were 10 ng/1 and 4.9 ng/1, respectively (shown by the dashed
lines where the lower line represents the one for the present
IEMA). The assay results below the lowest detectable concentra-
tion obtained with the Gamma BCT Intact PTH IRMA are shown
by arrows. The samples were run in duplicate as described in the
Methods.
the legal requirements for experimental animals. As
distant phylogenetic relatives of mammals, avians may
provide new epitopes, especially for antigens from
mammalian origin. As shown in the present study, the
(1—84) polypeptide that was used as antigen raised
antibodies only against the carboxy-terminal site of
the protein in the rabbits and mice, while only poor
responses were found against the amino terminal parts.
Conversely, the hens raised almost equal antibody re-
sponse against both the N- and C-terminal sites of
parathyrin. By using the alkaline elution buffer in
immunoaffinity chromatography, we obtained up to
milligram quantity highly reactive site specific anti-
bodies from each egg yolk. As found in our previous
studies (8, 9), also rabbit and even mouse IgM-class
antibodies preserved well their antigen binding ability
with this technique. Although hen serum antibodies
have been previously utilized in radioirnmunometric
parathyrin assay (10) and as a detection antibody in
immunoradiometric parathyrin assay, the yolk antibody
technology offers more inexpensive and convenient
source of antibodies for parathyrin assays.
All the different antibody combinations used to measure
intact parathyrin in the IEMA format gave slightly dif-
ferent reaction specificity and sensitivity. The IEMA
with the best combination, the hen anti-parathyrin
(1—30) for capture and the biotinylated hen anti-para-
thyrin (49—84) for detection, was very well comparable
to the other radiometric or chemiluminometric assays
developed for intact parathyrin in respect of assay per-
formance, showing a strong correlation with the com-
mercial radiometric assays. The difference in reactivity
between the parathyrin standards in our IEMA (fig. 5)
was probably due to different assay matrices, since the
standards for the IRMA were prepared in swine serum.
The matrix effect and the different standard preparations
have been previously shown to affect the parathyrin as-
says (11).
Determination of the parathyrin concentration in sys-
temic circulation is utilized in the diagnostics of physio-
logical disorders related to altered parathyroid gland
function and calcium ion balance in the body (12-14).
Numerous immunometric methods for the determination
of circulating parathyrin have been developed with spec-
ificity to the biologically active aminoterminal sequence
(1—34) (15), the enzymatic cleavage site at (44—68)
(16, 17) or the intact polypeptide (1-84) (18, 19), but
methods using two different antibody preparations di-
rected against opposite ends of the parathyrin polypep-
tide are preferred because of their superior assay perfor-
mance and clinical utility (20, 21). The present IEMA
using the new hen egg yolk antibodies offers a very sen-
sitive non-radioactive tool for the determination of the
intact human parathyrin, even at levels well below the
lower limit of the currently established normal range
(fig. 6). So far, only a few methods performing sensitiv-
ity below 10 ng/1 have been developed with chemilumi-
niscence or radioiodine detection (22—23). In terms of
sensitivity and all other analytical properties, our IEMA
is comparable to those methods, but it offers the advan-
tage of requiring relatively inexpensive laboratory in-
strumentation. The diagnostic utility of the present
IEMA in the parathyrin-related disorders is under further
examination.
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